血栓通注射液联合巴曲酶治疗突发性耳聋合并代谢综合征的临床观察
作者:
基金项目:

淮南市科技计划项目(2013A4305)。


Effect of Xueshuantong injection combined with batroxase in the treatment of sudden deafness complicated with metabolic syndrome
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
    摘要:

    目的 探讨血栓通注射液联合巴曲酶治疗突发性耳聋合并代谢综合征的临床效果及对患者血清血液流变学的影响。方法 选择2017年10月—2019年10月淮南东方医院集团总院收治的突发性耳聋合并代谢综合征患者100例,随机分为两组,对照组患者(n=50)给予巴曲酶、补充维生素和营养神经的常规治疗方式;观察组患者(n=50)在对照组治疗基础上加用血栓通注射液,比较两组治疗前后听力阈值及包括血浆黏度、全血黏度、凝血酶时间、凝血酶原时间、活化部分凝血酶原时间、纤维蛋白原、血小板因子在内的血清血液流变学指数。结果 治疗后,两组患者血浆黏度和全血高切黏度、中切黏度、低切黏度、纤维蛋白原、血小板因子水平与治疗前相比均显著降低;凝血酶时间、凝血酶原时间、活化部分凝血酶原时间、血清连接蛋白26和血清连接蛋白30水平均显著升高;两组患者治疗后测得听力阈值较治疗前均显著降低,且观察组听力阈值改善程度显著高于对照组,差异均具有统计学意义(P<0.05)。结论 血栓通注射液联合巴曲酶可有效改善突发性耳聋合并代谢综合征患者血液高凝状态,上调血清连接蛋白26和连接蛋白30水平,有效改善患者内耳微循环,减轻听力损伤。

    Abstract:

    Objective To investigate the effect of Xueshuantong injection in the treatment of sudden deafness complicated with metabolic syndrome and its effect on serum hemorheology.Methods A total of 100 patients with sudden deafness complicated with metabolic syndrome admitted to General Hospital of Huainan Oriental Hospital Group from October 2017 to October 2019 were selected and randomly divided into two groups:the control group (n=50) was given the routine treatment of batroxase,supplementation of vitamins and neuronutrition; the observation group (n=50) was treated with Xueshuantong injection on the basis treatment of the control group. The differences between the two groups before and after treatment were compared, including hearing threshold and serum hemorheology indexes of plasma viscosity, whole blood viscosity, thrombin time, prothrombin time, activated partial prothrombin time, fibrinogen and platelet factor.Results After treatment compared to before treatment, plasma viscosity and whole blood high-cut viscosity, medium-cut viscosity and low-cut viscosity were significantly decreased in two groups, but the levels of thrombin time, prothrombin time, activated partial prothrombin time, Connexin 26 and Connexin 30 were significantly increased; After treatment, the hearing threshold of 2 groups was significantly lower, and the improvement degree of the corresponding indicators in the observation group was significantly higher than that in the control group, which was statistical significance (P<0.05).Conclusion Xueshuantong injection combined with Batroxase can effectively improve the hypercoagulability of blood in patients with sudden deafness complicated with metabolic syndrome, increase the levels of serum connectin 26 and connectin 30, and effectively improve the microcirculation and hearing of patients.

    参考文献
    相似文献
    引证文献
引用本文

李哲,蔡克万,王政林.血栓通注射液联合巴曲酶治疗突发性耳聋合并代谢综合征的临床观察[J].中国耳鼻咽喉颅底外科杂志,2021,27(5):589-593

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2021-05-11
  • 在线发布日期: 2021-10-29
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭